Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paola Grandi

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Drug Discovery Today. Technologies|June 16, 2019
Advanced proteomics approaches to unravel protein homeostasisPaola Grandi, Marcus Bantscheff
Molecular Therapy Oncolytics|October 19, 2020
Updates on Oncolytic Virus Immunotherapy for CancersCole Peters, Paola Grandi, Fares Nigim
Science (New York, N.Y.)|November 6, 2004
Jet and accretion-disk emission untangled in 3C 273Paola Grandi, Giorgio G C Palumbo
Trends in Pharmacological Sciences|July 3, 2021
Screening strategies for identifying RNA- and ribonucleoprotein-targeted compoundsWilliam J Martin, Paola Grandi, Marco Marcia
Current Opinion in Chemical Biology|August 4, 2020
Domain-selective targeting of BET proteins in cancer and immunological diseasesMassimo Petretich, Emmanuel H Demont, Paola Grandi
Methods (San Diego, Calif.)|May 4, 2004
Targeting HSV amplicon vectorsPaola Grandi, Matthew Spear, Xandra O Breakefield, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 6, 2023
Intravesical Infusion of Oncolytic Virus CG0070 in the Treatment of Bladder CancerPaola Grandi, Andrea Darilek, Anay Moscu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 7, 2026
2025 Advancing Cell and Gene Therapies for Cancer post-meeting reportPaola Grandi, Maria G Castro, Evanthia Galanis, et al.
Expert Review of Neurotherapeutics|April 7, 2009
Design and application of oncolytic HSV vectors for glioblastoma therapyPaola Grandi, Pierpaolo Peruzzi, Bonnie Reinhart, et al.
Journal of Virology|November 16, 2012
Novel mutations in gB and gH circumvent the requirement for known gD Receptors in herpes simplex virus 1 entry and cell-to-cell spreadHiroaki Uchida, Janet Chan, Indira Shrivastava, et al.
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Drug Discovery Today. Technologies|June 16, 2019
Advanced proteomics approaches to unravel protein homeostasisPaola Grandi, Marcus Bantscheff
Molecular Therapy Oncolytics|October 19, 2020
Updates on Oncolytic Virus Immunotherapy for CancersCole Peters, Paola Grandi, Fares Nigim
Science (New York, N.Y.)|November 6, 2004
Jet and accretion-disk emission untangled in 3C 273Paola Grandi, Giorgio G C Palumbo
Trends in Pharmacological Sciences|July 3, 2021
Screening strategies for identifying RNA- and ribonucleoprotein-targeted compoundsWilliam J Martin, Paola Grandi, Marco Marcia
Current Opinion in Chemical Biology|August 4, 2020
Domain-selective targeting of BET proteins in cancer and immunological diseasesMassimo Petretich, Emmanuel H Demont, Paola Grandi
Methods (San Diego, Calif.)|May 4, 2004
Targeting HSV amplicon vectorsPaola Grandi, Matthew Spear, Xandra O Breakefield, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 6, 2023
Intravesical Infusion of Oncolytic Virus CG0070 in the Treatment of Bladder CancerPaola Grandi, Andrea Darilek, Anay Moscu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 7, 2026
2025 Advancing Cell and Gene Therapies for Cancer post-meeting reportPaola Grandi, Maria G Castro, Evanthia Galanis, et al.
Expert Review of Neurotherapeutics|April 7, 2009
Design and application of oncolytic HSV vectors for glioblastoma therapyPaola Grandi, Pierpaolo Peruzzi, Bonnie Reinhart, et al.
Journal of Virology|November 16, 2012
Novel mutations in gB and gH circumvent the requirement for known gD Receptors in herpes simplex virus 1 entry and cell-to-cell spreadHiroaki Uchida, Janet Chan, Indira Shrivastava, et al.
Pageof 8